Mouse anti Cytomegalovirus gH Late Neutralizing Antigen antibody, clone HCMV16 (51C1) recognizes Cytomegalovirus glycoprotein H (gH) late neutralizing antigen and reacts with MRC-5 infected cells. Mouse anti Cytomegalovirus gH Late Neutralizing Antigen antibody, clone HCMV16 (51C1) does not react with HSV, VZV, EBV or uninfected cells.
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein A
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- Carrier Free
- Cytomegalovirus extracts.
- Approx. Protein Concentrations
- 1.0 mg/ml
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- 12 months from date of despatch
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of Cytomegalovirus gH Late Neutralizing Antigen antibody
|Immunohistology - Frozen
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
References for Cytomegalovirus gH Late Neutralizing Antigen antibody
Cranage, M.P. et al. (1988) Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
J Virol. 62 (4): 1416-22.
Hamilton, A.A. et al. (1997) A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections.
J Infect Dis. 176 (1): 59-68.
Milne, R.S. et al. (1998) Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without.
J Gen Virol. 79 ( Pt 4): 855-65.